0.20
0.20 (0%)
As of May 24, 2023
Athenex, Inc. [ATNX]
Source:
Company Overview
Athenex, Inc., together with its subsidiaries, is a clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development and commercialization of next-generation products for the treatment of cancer. Our mission is to become a leader in bringing innovative cancer treatments to the market and to improve patient health outcomes.
| Country | United States |
| Headquarters | buffalo, new york |
| Phone Number | 716-898-8625 |
| Industry | manufacturing |
| CEO | Johnson Y.N. Lau |
| Website | www.athenex.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $0 |
| Net Income | $0 |
| Net Cash | $0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | |
| Return on Assets | |
| Turnover Ratio | 0% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $0 |
| Total Liabilities | $0 |
| Operating Cash Flow | $0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
